Yang Zhang

发表

RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin–proteasome pathway contributes to the reversion of ATRA resistance

Guoyu Hu, Guangsen Zhang, Yewei Wang, 2019, Cancer Cell International.

The JAK2 inhibitor TG101209 exhibits anti-tumor and chemotherapeutic sensitizing effects on Burkitt lymphoma cells by inhibiting the JAK2/STAT3/c-MYB signaling axis

Guangsen Zhang, Xiang Xiao, Zhihua Wang, 2021, Cell death discovery.

A novel germline HAVCR2 (TIM-3) compound heterozygous mutation is related to hemophagocytic lymphohistiocytic syndrome in EBV-positive peripheral T-cell lymphoma (NOS) with down-regulated TIM-3 signaling

Guoyu Hu, Guangsen Zhang, Yun-xiao Xu, 2022, Frontiers in Oncology.

A novel NAP1L4/NUTM1 fusion arising from translocation t(11;15)(p15;q12) in a myeloid neoplasm with eosinophilia and rearrangement of PDGFRA highlights an unusual clinical feature and therapeutic reaction

Guangsen Zhang, Yewei Wang, Yun-xiao Xu, 2020, Annals of Hematology.

A novel SART3::RARG fusion gene in acute myeloid leukemia with acute promyelocytic leukemia phenotype and differentiation escape to retinoic acid

Guangsen Zhang, Yun-xiao Xu, Ji Li, 2022, Haematologica.

GTF2I‐RARA is a novel fusion transcript in a t(7;17) variant of acute promyelocytic leukaemia with clinical resistance to retinoic acid

Guang-Biao Zhou, Sufang Liu, Guang-sen Zhang, 2015, British journal of haematology.

Neoadjuvant chemotherapy plus surgery versus concurrent chemoradiotherapy in stage IB2-IIB cervical cancer: A systematic review and meta-analysis

Chunhong Hu, Wen Zou, Yang Zhang, 2019, PloS one.

Coagulation Factor XIII Subunit A Is a Biomarker for Curative Effects and Prognosis in Malignant Solid Tumors, Especially Non-small Cell Lung Cancer

Chunhong Hu, Guangsen Zhang, Ji Li, 2021, Frontiers in Oncology.

LUX-Lung 7: is there enough data for a final conclusion?

Chunhong Hu, Fang Wu, Yang Zhang, 2016, The Lancet. Oncology.

A small molecular compound CC1007 induces cross-lineage differentiation by inhibiting HDAC7 expression and HDAC7/MEF2C interaction in BCR-ABL1− pre-B-ALL

Yongheng Chen, Lin Chen, Guoyu Hu, 2020, Cell Death & Disease.

Coexistence of JAK2V617F Mutation and BCR-ABL1 Transcript in Two Chinese Patients with Chronic Myelogenous Leukemia

Xiang Xiao, Sufang Liu, Guang-sen Zhang, 2011, Acta Haematologica.

RNF8 is responsible for ATRA resistance in variant acute promyelocytic leukemia with GTF2I/RARA fusion, and inhibition of the ubiquitin–proteasome pathway contributes to the reversion of ATRA resistance

Guoyu Hu, Guangsen Zhang, Yewei Wang, 2019, Cancer Cell International.